ARID1A and ovarian carcinoma: To follow up on these observations, we used KH‐4‐43 to validate this sensitivity in an expanded panel of seven additional ovarian cancer cell lines representing various subtypes and housing a diverse array of mutations in known ovarian cancer driver genes such as TP53, PIK3CA, and ARID1A (Figure 2C, Table S2).